Media Articles Related to Benzoyl Peroxide Wash (Benzoyl Peroxide)
Galderma receives FDA approval for new antibiotic-free treatment option for acne patients
Source: Dermatology News From Medical News Today [2015.07.20]
Galderma Laboratories, L.P. has announced that the U.S. Food and Drug Administration (FDA) approved antibiotic-free Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.
Nanoparticles used to prevent inflammatory acne through slow-released nitric oxide
Source: Dermatology News From Medical News Today [2015.07.16]
GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology.
Acne Pictures Slideshow: Quick Cover-ups, Do's and Don'ts
Source: MedicineNet Acne Specialty [2015.06.26]
Title: Acne Pictures Slideshow: Quick Cover-ups, Do's and Don'ts
Created: 8/1/2012 12:00:00 AM
Last Editorial Review: 6/26/2015 12:00:00 AM
Could a Vitamin Play a Role in Acne Outbreaks?
Source: MedicineNet Acne Specialty [2015.06.25]
Title: Could a Vitamin Play a Role in Acne Outbreaks?
Category: Health News
Created: 6/24/2015 12:00:00 AM
Last Editorial Review: 6/25/2015 12:00:00 AM
Acne patients: 'substantial proportion' fail to collect prescribed treatment
Source: Compliance News From Medical News Today [2015.03.22]
Dermatologist-prescribed treatments are being left on pharmacy shelves by up to a quarter of people with acne, according to a new study.
Published Studies Related to Benzoyl Peroxide Wash (Benzoyl Peroxide)
The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in
the treatment of mild acne vulgaris: a randomized trial. 
Topical treatments, such as adapalene and benzoyl peroxide (BPO), are popular in
mild-to-moderate acne vulgaris... Both topical adapalene 0.1% and BPO 2.5% gels seem
safe and effective in mild acne vulgaris, with a marginal tendency toward the
Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel:
efficacy and tolerability of treatment in moderate to severe acne. 
efficacy of acne medications in skin of color... CONCLUSIONS: Acne subjects with Fitzpatrick skin types IV-VI were not found to be
Treatment of moderate to severe acne vulgaris in a Hispanic population: a
post-hoc analysis of efficacy and tolerability of clindamycin phosphate
1.2%/benzoyl peroxide 2.5% gel. 
in Hispanics... CONCLUSIONS: Overall efficacy and tolerability with clindamycin phosphate
Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. [2011.11]
BACKGROUND: Topical therapy with comedolytics and antibiotics are often advocated for mild and moderate severity acne vulgaris. Nadifloxacin, a new fluoroquinolone with anti-Propionibacterium acnes activity and additional anti-inflammatory activity, is approved for use in acne. This randomized controlled assessor blind trial compared the clinical effectiveness and safety of eight weeks therapy of nadifloxacin 1% versus clindamycin 1% as add-on therapy to benzoyl peroxide (2.5%) in mild to moderate grade acne... CONCLUSIONS: Topical nadifloxacin, a new fluoroquinolone is effective, tolerable, and safe for mild o moderate facial acne. Its clinical effectiveness is comparable to clindamycin when used as add-on therapy to benzoyl peroxide.
Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study. [2011.08]
BACKGROUND: Oral antibiotics in association with a topical retinoid with or without benzoyl peroxide (BPO) are the recommended first-line option in the treatment of moderate to severe acne vulgaris. OBJECTIVES: To evaluate the efficacy and safety of oral lymecycline 300 mg with adapalene 0.1%-BPO 2.5% (A/BPO) fixed-dose gel in comparison with oral lymecycline 300 mg with a vehicle gel in subjects with moderate to severe acne vulgaris... CONCLUSION: These results demonstrate the clinical benefit of combining A/BPO with lymecycline in the treatment of moderate to severe acne vulgaris. (c) 2011 The Authors. BJD (c) 2011 British Association of Dermatologists 2011.
Clinical Trials Related to Benzoyl Peroxide Wash (Benzoyl Peroxide)
A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duacï¿½ Topical Gel in the Treatment of Acne Vulgaris [Recruiting]
The objective of this study is to compare the relative efficacy and safety of the test
formulation Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Taro Pharmaceuticals Inc.) to
the marketed formulation Duac® Topical Gel (Clindamycin 1%/Benzoyl Peroxide 5%) (Stiefel) in
the treatment of the inflamed lesions of acne vulgaris. Both the test and reference
formulations will also be compared to a placebo formulation to test for superiority.
Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanyaï¿½ Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris [Recruiting]
The objective of this study is to compare the safety and efficacy profiles of Taro
Pharmaceutical Inc.'s Clindamycin Phosphate and Benzoyl Peroxide Gel 1. 2%/2. 5% to Acanya®
(Clindamycin Phosphate and Benzoyl Peroxide) Gel, 1. 2%/2. 5% and to demonstrate the superior
efficacy of the two active formulations over that of the vehicle in the treatment of acne
Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduoï¿½ and Both to a Placebo Control in the Treatment of Acne Vulgaris [Recruiting]
Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects. [Recruiting]
This is a multicenter, randomized, double-blinded, vehicle-controlled, parallel-group study
in Japanese subjects with acne vulgaris to demonstrate the efficacy of GI148512 (benzoyl
peroxide [BPO] 3% gel) when applied once daily for 12 weeks. This study will also evaluate
the safety of GI148512 when applied topically once daily for 12 weeks.
Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris [Not yet recruiting]
The purpose of this study is to demonstrate the efficacy of Adapalene 0. 1%/Benzoyl Peroxide
2. 5% Gel in the treatment of acne vulgaris. The safety will also be evaluated.